![Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5938/TOC-Subject-Sample-2021-Health-Social-Care.jpg"})
Abstract
Objective: This article describes the current clinical treatment approaches for MD. Study design: Acute and chronic current pharmacological treatments in Ménière's disease (MD) are reviewed. Results: All treatments for MD are focused on treating the symptoms and are prophylactic to prevent further attacks. Medical management includes sodium restriction and the avoidance of caffeine, alcohol and nicotine. An evidence base for the management of patients with MD is still lacking. Conclusion: The outcome of treatment of MD is difficult to assess. The medical management of MD is still empiric and based on lifestyle changes and pharmacotherapy that remain the primary therapy in definite MD, while ablative and transtympanic therapies represent the treatment of second choice.
Declaration of interest: The authors report no conflicts of interest in this paper.